We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Over the last 10 years, generic drugs have saved the U.S. healthcare system about $1.68 trillion. 2016 was a record-setting year for FDA’s generic drug program.
Year 2016 was a mixed year for the pharma industry with increasing number of acquisitions and mergers, foreign investments, layoffs, regulatory hurdles and new challenges. Biospectrum takes a look at the top Mergers and Acquisitions in 2016